News
8
minutes reading time
InnoSIGN aims to increase survival rates of cancer patients using PCR testing
With a technology developed at Philips, InnoSIGN seeks to provide as many cancer patients as possible with optimal treatment which can ultimately save lives - this team of experienced specialists won the start-up a Gerard and Anton Award.
